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Abstract 
Uncertainty exists over the efficacy and safety of endovascular treatment in patients with large 
ischemic cores in anterior circulation. Several trials have shown some potential benefits in se-
lected patients despite their late presentation. In particular, perfusion imaging modalities 
equipped with automatic software has been proven useful in identifying patients with large 
ischemic cores that are at risk of infarct core expansion, meaning that this specific patient 
group could still benefit from reperfusion treatment. We reported a case of late-presenting 
and progressing acute ischemic stroke who was selected by perfusion imaging with RAPID 
software and successfully underwent endovascular thrombectomy. On admission, her National 
Institutes of Health Stroke Scale (NIHSS) score was 7. Computed tomography angiography 
showed complete occlusion of the proximal right middle cerebral artery. Subsequent advanced 
perfusion imaging with automatic software showed that the ischemic core was 88 mL, Tmax  
>6 s volume was 131 mL, and mismatch volume was 43 mL. She was rapidly transferred to the 
Cath lab for thrombectomy with a stent retriever. Her NIHSS score was 15 before the 
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endovascular procedure. She had a dramatic recovery with an NIHSS score of 4 at 24-h after 
the procedure. She was discharged on day 9 with a modified Rankin Score of 1. Our findings 
suggest that endovascular treatment can be beneficial to the patients, particularly younger 
ones, with large ischemic cores with the aid of perfusion imaging. © 2020 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Multiple studies demonstrated that acute ischemic stroke (AIS) patients with a large core 
volume (irreversibly damaged tissue), usually ≥70mL, had a low rate of favorable outcomes, 
ranging from 0 to 21% [1]. A recently Multiple Endovascular Stroke Trials (HERMES) meta-
analysis suggests that the rate of symptomatic hemorrhagic transformation is increased in 
stroke patients with a large core volume who underwent mechanical thrombectomy (MT) [2]. 
Endovascular intervention (EVT), which has been proven to be the most effective treatment 
in the acute phase of stroke with large artery occlusion, was deemed futile for patients with 
large infarct core. A core volume greater than 70 mL was considered to be an exclusion crite-
rion for reperfusion therapy in most clinical trials. However, this concept came from the stud-
ies conducted in patients receiving intravenous thrombolysis whereby a higher rate of symp-
tomatic intracerebral hemorrhage and poorer outcomes can be attributable to malignant pro-
file [1]. Recently, there has been some evidence that patients who present within 6 h with a 
core volume ≥70 mL may still benefit from EVT, which was potentially related to high reper-
fusion rates observed in these studies [3]. The SELECT study suggests that there are potential 
benefits for patients with large cores up to 24 h from the time last known to be well, who were 
selected based on an Alberta Stroke Program Early CT Score (ASPECTS) of less than 6, or a 
volume with a relative cerebral blood flow <30% of ≥50 cm3 on CT perfusion scanning [4].  
We present a case of MT in a patient with a large ischemic core who showed dramatical recov-
ery [5]. 
Case Presentation 
We reported a case of late-presenting and progressing AIS successfully undergoing endo-
vascular thrombectomy. Our patient is a 55-year-old female presenting at our hospital with 
left hemiparesis and headache. Upon hospitalization at our center at 15:30, it was more than 
16 h since she was last seen well at 23:00 the day before going to sleep. Her admission NIHSS 
score was 7, with only mild left-sided hemiparesis and paresthesia. Subsequent non-contrast 
computed tomography (NCCT) revealed a large infarction core and an Alberta stroke program 
early CT score (ASPECTS) of 5 (Fig. 1a). Her past medical history was uncertain with only un-
known valvulopathy noted. A computed tomography angiography was later performed, which 
revealed an occlusion site at the proximal segment of the right middle cerebral artery. During 
the imaging procedure, her clinical status worsened with severe left hemiparesis and an in-
creased NIHSS score from 7 to 15. We decided to obtain a perfusion-weighted MRI scan, using 
RAPID software to determine the salvageable zone. Core volume (as defined by an apparent 
diffusion coefficient threshold less than 620 × 10–6 mm2/s) was estimated to be 88 mL and 
mismatch volume (as defined by a Tmax >6 s volume subtracted by the core volume) was 43 
mL (Fig. 2a). We then decided to perform MT with the consent of her family. During the 2-h 
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procedure, we managed to remove multiple small thrombi after five attempts using the Soli-
taire stent retriever and eventually achieved TICI-3 recanalization. NCCT was repeated the 
next day which showed cerebral hemorrhage of parenchymal hematoma type 1 (PH1). At  
24-h check-up, her neurological functions recovered remarkably with an NIHSS score of 4. On 
day 4, perfusion imaging was repeated to estimate the final infarct core volume (Fig. 2b). On 
day 6, NCCT was repeated showing extended infarct and a quick absorption of cerebral hem-
orrhage (Fig. 1b). The etiology of her stroke remains uncertain in the absence of large vessel 
atherosclerosis on vascular imaging, though an embolism was suspected. We decided to start 
clopidogrel, rosuvastatin, and perindopril. On day 9, she was discharged with an NIHSS score 
of 3. 
Discussion 
Currently, there is no evidence on the treatment of AIS patients with large ischemic cores, 
often defined as an ASPECTS <6 or an ischemic core volume greater than 50–70 mL. A recent 
meta-analysis of individual participant data of five major thrombectomy trials did not observe 
treatment benefits in patients with an ASPECTS of 5 or less [2]. However, with advanced im-
aging selection, EVT may be beneficial in patients with large infarct core on MRI-DWI or per-
fusion CT [6]. Although the patient was not fulfilling inclusion criteria of both DAWN and DE-
FUSE 3 (ASPECTS <6, cores >70 mL, mismatch ratio <1.8), she did have a relatively large pe-
numbra. Her absolute mismatch volume was 43 ml, which was larger than the minimum 15 
mL required by DEFUSE 3, and fulfilled mismatch criteria of other trials (e.g., EXTEND-IA 
which required a mismatch >10 mL and mismatch ratio >1.2) [7–9]. Proper patient selection 
is therefore critical, and advanced imaging techniques have been developed to identify those 
who can benefit from reperfusion treatment [6]. There was no significant difference in major 
intracranial hemorrhage in the SELECT study. Moreover, hemicraniectomy and 90-day mor-
tality rates were lower in the endovascular treatment group [10]. They suggested EVT was 
relatively safe. Other studies showed that young acute stroke patients who have a large is-
chemic core and large mismatch imaging profile might still benefit from EVT [6, 11]. On the 
contrary, patients older than 75 years have a higher risk of poor outcomes with EVT [6]. Alt-
hough the follow-up NCCT and MRP (perfusion-weighted MRI) showed extended infarct, sav-
ing 15–20 mL of the penumbra can make an important effect in improving outcomes. There-
fore, this case suggests that in young large-vessel occlusion patients presenting in a late time 
window with a large infarct core, endovascular therapy could still be considered on a case-by-
case basis. Our decision was based on the patient’s large mismatch volume (43 mL) and 
younger age (<60 years old). 
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Fig. 1. The initial NCCT showed a low ASPECTS score of 5 (a, b). On day 6, NCCT was repeated showing a 
change in infarct size after EVT and a quick absorption of cerebral hemorrhage (c, d). L, lentiform nucleus; 
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Fig. 2. Perfusion magnetic resonance imaging with RAPID software showed a large mismatch volume (a). 
Perfusion imaging was repeated to estimate the final infarct core volume (b), demonstrating that 26 mL of 
the penumbra was saved. 
 
